Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria

NCT02922413 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT02922413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Phase 2
Overall status
Terminated
Start date
October 30, 2015
Completion date
December 27, 2023
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute intermittent porphyria, hereditary coproporphyria, variegate porphyria